Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04855643 · ClinicalTrials.gov registry record · NA
Home-based tDCS for Apathy in Alzheimer's Disease
A NA study, sponsored by The University of Texas Health Science Center, Houston.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT04855643: Clinical Trial NA study, sponsored by The University of Texas Health Science Center, Houston.
NCT04855643 is a NA study that was terminated before completion, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 3 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04855643, a NA study, was terminated before completion, sponsored by The University of Texas Health Science Center, Houston.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to assess feasibility, acceptability, and safety of providing tDCS to Alzheimer's disease and related dementias (ADRD) patients with apathy and to assess the efficacy of tDCS for ADRD-related symptoms, with a primary focus on apathy.
Primary Outcome
The feasibility will be assessed based on the recruitment rate (per month), randomization success, blind success, retention, and attrition rates.
Interventions
- DEVICE home-based active tDCS
- DEVICE home-based sham tDCS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2021-08-20 |
| Est. Completion | 2022-07-10 |
| Phase | NA |
Why NCT04855643 stopped before completion
NCT04855643 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which home-based active tDCS is the first listed.
NCT04855643 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04855643 about?
NCT04855643 is a clinical study titled "Home-based tDCS for Apathy in Alzheimer's Disease". The purpose of this study is to assess feasibility, acceptability, and safety of providing tDCS to Alzheimer's disease and related dementias (ADRD) patients with apathy and to assess the efficacy of tDCS for ADRD-related symptoms, with a primary focus on apathy.
What is the current status of trial NCT04855643?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2021-08-20. Estimated completion is 2022-07-10.
What interventions are being tested in trial NCT04855643?
The interventions under investigation include: home-based active tDCS (DEVICE), home-based sham tDCS (DEVICE).
Who is sponsoring clinical trial NCT04855643?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04855643's enrollment target sits among peer trials
3 1996th of 2000 higher than 4 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI